We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
INTEGRA BIOSCIENCES AG

Download Mobile App




A Subpopulation of Melanoma Cells Lacks VEGFR and Resists Antiangiogenic Therapy

By LabMedica International staff writers
Posted on 05 Nov 2014
Melanoma researchers have discovered a subpopulation of cancer cells that generate new blood vessels by expressing the vascular cell adhesion molecule PECAM1 (platelet endothelial cell adhesion molecule), but not VEGFR-2 (vascular endothelial growth factor), the major signaling molecule normally associated with new blood vessel formation (angiogenesis).

PECAM-1 also known as cluster of differentiation 31 (CD31) is a protein that in humans is encoded by the PECAM1 gene found on chromosome 17. More...
PECAM-1 plays a key role in removing aged neutrophils from the body. It is found on the surface of platelets, monocytes, neutrophils, and some types of T-cells, and makes up a large portion of endothelial cell intercellular junctions. This protein is a member of the immunoglobulin superfamily and is likely involved in leukocyte migration, angiogenesis, and integrin activation.

Investigators at the University of North Carolina (Chapel Hill, USA) were searching for an explanation as to why antiangiogenic drugs targeted at VEGFR often failed to prevent melanoma growth and spread. Towards this end, they reported in the October 22, 2014, online edition of the journal Nature Communications that they had isolated what appeared to be noncancerous endothelial cells from melanoma tumors. However, genetic analysis revealed that these cells resembled cancer cells rather than endothelial cells, and that these cells did not express VEGFR.

Instead of VEGFR these cells expressed the vascular cell adhesion molecule PECAM1 and participated in a PECAM1-dependent form of angiogenesis. Clonally derived PECAM1-positive tumor cells coalesced to form PECAM1-dependent networks in vitro, and they generated well-perfused, VEGF-independent channels in mice.

“These cells looked very different from normal endothelial cells in cultures,” said senior author Dr. Andrew C. Dudley, assistant professor of cell biology and physiology at the University of North Carolina. “We did not know what these cells were. Over the course of a year we found that these cells had several markers similar to melanoma cells. For a long time the hope has been that antiangiogenic therapies would starve tumors of the nutrients they need to thrive, but these drugs have not worked as well as we all had hoped. There are likely several reasons why these drugs have not been effective; our research suggests that these previously uncharacterized cells could be one of the reasons.”

Related Links:
University of North Carolina


Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
New
Drug Testing Assays
Atellica DT 250 Analyzer
New
Portable POCT Blood Gas Analyzer
BD100
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: (a) CTC separation using contraction-expansion inertial microfluidics. (b) CTC detection using the YOLOv8 deep learning model. (Image Credit: Junyi Ouyang, Haiqin Li)

Label-Free Platform Combines Microfluidics and AI for Circulating Tumor Cell Analysis

Liquid biopsy relies on detecting rare tumor-derived material in blood, but circulating tumor cells (CTCs) are especially difficult to capture because they are vastly outnumbered by normal blood cells.... Read more

Molecular Diagnostics

view channel
Image: Congenital cytomegalovirus can go unnoticed at birth despite later risks to hearing and development (Image Credit: 123RF)

Pooled Saliva PCR Screening Identifies Congenital CMV Missed by Targeted Testing

Congenital cytomegalovirus (cCMV) can be present in newborns who appear healthy and pass routine hearing screening. The infection is one of the most common maternal-to-fetal infections during pregnancy... Read more

Microbiology

view channel
Image Credit: 123RF

FDA-Cleared Multiplex PCR Test Detects 13 Respiratory Pathogens in a Single Sample

Respiratory tract infections can be difficult to distinguish at presentation because many cause overlapping, nonspecific symptoms and are initially grouped as influenza-like illnesses. Causes span a range... Read more

Technology

view channel
Image: The laser-based photoacoustic spectroscopy setup consists of a Mid-IR laser equipped with three QCL modules covering wavelengths from 5.6 μm to 12.9 μm, two silver coated mirrors (SCM), a dichroic mirror (DM) with a transmittance of 90%, a thermal power sensor head (PM) to monitor the output laser power, a mechanical chopper (MC) for frequency modulation and a CEPAS-detector with a self-designed swab holder (SH). (Credit: Graunke, T., Scholz, T., Pieniak, M. et al. Scientific Reports (2026). https://doi.org/10.1038/s41598-026-68298-9)

Laser-Based Swab Analysis Shows Promise for Detecting Disease-Linked Odor Patterns

Disease-related changes in volatile organic compounds can alter body odor, producing measurable patterns in exhaled breath and bodily fluids. Current analytical methods can be complex, time-consuming,... Read more

Industry

view channel
Image

Collaboration Combines AI Cognitive Assessment and RNA Blood Testing for Earlier Alzheimer’s Detection

Alzheimer’s disease is often identified only after substantial neurodegeneration, partly because current diagnostic pathways are fragmented and difficult to scale. As treatment shifts toward earlier intervention,... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.